Denali Therapeutics is a biotechnology company based in South San Francisco, CA, dedicated to defeating neurodegenerative diseases through rigorous therapeutic discovery and development. With a focus on Alzheimer's disease, Parkinson's disease, ALS, and other neurodegenerative diseases, Denali utilizes groundbreaking scientific insights and deep expertise in genetics and pathology to develop effective molecular therapeutics.
Driven by a commitment to partnering with patients, Denali's core portfolio consists of programs at various stages of clinical and preclinical development, aiming to directly address the causes and risk factors of neurodegenerative diseases. With a team of passionate scientists and drug developers, Denali believes in the power of collaboration and is continuously seeking new assets, technologies, and scientific insights to advance their mission of defeating degeneration.
Generated from the website